Abstract
We present an approach to studying and predicting the spatio-temporal progression of infectious diseases. We treat the problem by adopting a partial differential equation (PDE) version of the Susceptible, Infected, Recovered, Deceased (SIRD) compartmental model of epidemiology, which is achieved by replacing compartmental populations by their densities. Building on our recent work (Computational Mechanics, 66, 1177, 2020), we replace our earlier use of global polynomial basis functions with those having local support, as epitomized in the finite element method, for the spatial representation of the SIRD parameters. The time dependence is treated by inferring constant parameters over time intervals that coincide with the time step in semi-discrete numerical implementations. In combination, this amounts to a scheme of field inversion of the SIRD parameters over each time step. Applied to data over ten months of 2020 for the pandemic in the US state of Michigan and to all of Mexico, our system inference via field inversion infers spatio-temporally varying PDE SIRD parameters that replicate the progression of the pandemic with high accuracy. It also produces accurate predictions, when compared against data, for a three week period into 2021. Of note is the insight that is suggested on the spatio-temporal variation of infection, recovery and death rates, as well as patterns of the population’s mobility revealed by diffusivities of the compartments.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
We acknowledge the support of Defense Advanced Research Projects Agency (DARPA) under Agreement No. HR0011199002, "Artificial Intelligence guided multi-scale multi-physics framework for discovering complex emergent materials phenomena"
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
N/A
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Paper in collection COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv
The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, University of Washington, and Vrije Universiteit Amsterdam.